Short Interest in Aditxt, Inc. (NASDAQ:ADTX) Increases By 14.2%

Aditxt, Inc. (NASDAQ:ADTX) was the target of a large growth in short interest in the month of November. As of November 15th, there was short interest totalling 1,040,000 shares, a growth of 14.2% from the October 31st total of 910,800 shares. Currently, 7.3% of the shares of the company are short sold. Based on an average daily trading volume, of 2,690,000 shares, the short-interest ratio is presently 0.4 days.

Insider Buying and Selling

In related news, major shareholder Financial Lp Hrt sold 25,534 shares of Aditxt stock in a transaction dated Wednesday, October 16th. The shares were sold at an average price of $1.17, for a total transaction of $29,874.78. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.72% of the stock is currently owned by insiders.

Aditxt Stock Performance

Shares of Aditxt stock opened at $0.37 on Tuesday. The company has a 50-day simple moving average of $1.71 and a two-hundred day simple moving average of $34.90. Aditxt has a twelve month low of $0.31 and a twelve month high of $380.00.

Aditxt Company Profile

Aditxt, Inc, a biotech company, engages in the development and commercialization of technologies that focus on improving the health through monitoring and modulating the immune systems. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues.